جست‌وجوی استاد و پژوهشگر

Keykavous Parangمشاهده پروفایل

استاد

• Medicinal Chemistry
• Drug Delivery
• Antibacterial Peptides
• +۴ مورد دیگر

Dr. Keykavous Parang is a Professor at Chapman University with dual appointments in the School of Pharmacy and the Schmid College of Science and Technology. His expertise spans medicinal chemistry, drug delivery, and peptide nanotechnology, making significant contributions to both academic and pharmaceutical research fields. Dr. Parang has established himself as a leader in peptide-based drug delivery systems and antimicrobial research. Education: Doctor of Pharmacy from Tehran University of Medical Sciences (1989) Ph.D. in Medicinal Chemistry from University of Alberta, Canada (1997) Postdoctoral studies at University of Alberta, Rockefeller University, and Johns Hopkins University Research Interests: Dr. Parang's research focuses on the intersection of chemistry and biology, particularly on medicinal chemistry, organic chemistry, nanomedicine, and drug delivery. His work involves applying synthetic organic chemistry to biological challenges. Current research areas include utilizing cyclic and hybrid cyclic-linear peptides for drug delivery, designing peptides with antibacterial and antifungal properties, developing multifunctional agents with antiviral, anticancer, and antibacterial activities, and creating inhibitors for protein tyrosine kinases. His laboratory has made significant contributions to peptide-based drug delivery systems and antimicrobial peptide research. Publication Trends: Dr. Parang's recent publications (2024-2025) demonstrate a strong focus on peptide-based drug delivery systems, particularly cyclic and amphiphilic peptides for antimicrobial applications, cancer therapy, and nucleic acid delivery. His work shows increasing interdisciplinary collaboration across chemistry, biology, and pharmacology, with a growing emphasis on translational research that bridges basic science with clinical applications. The trend indicates expanding applications of peptide technology in addressing drug resistance challenges across multiple therapeutic areas. Scientific Awards: Academy of Pharmacy Professionals (APP) Academic Excellence Award (2024) Chapman University Million Dollar Club (2022) CUSP Culture Award: Diversity and Inclusion (2021) AIMS Award (2021) AACP Catalyst Program (Accelerating Research Leadership, 2017-2018) AACP Catalyst Program Fellowship (2017) AACP Teacher of the Year (2015) Listed among world's career top 2% of scientists by Stanford University (September 16, 2024) Top 12 Scientists at Chapman University (AD Scientific Index 2025) Advising and Grants: Dr. Parang has guided numerous faculty members and has supervised 25+ postdoctoral fellows and visiting scientists. Additionally, he has mentored 30+ graduate students and 65+ undergraduate students. His laboratory has been funded with $6.59 million from NIH, American Cancer Society, NSF, Industry, USAID-CONRAD, Kay Foundation, and many other funding agencies since October 2000. His research program demonstrates consistent funding success across multiple federal and private sources. Laboratories and Research Teams: Dr. Parang leads a multidisciplinary research group focusing on peptide chemistry and drug delivery systems. His laboratory has established infrastructure for peptide synthesis, characterization, and biological evaluation. The team includes graduate students, postdoctoral fellows, and undergraduate researchers working collaboratively on various aspects of peptide-based therapeutics. His leadership has helped establish research infrastructure and core facilities at Chapman University's School of Pharmacy.

Andreas Feigenspanمشاهده پروفایل

استاد

• Neurobiology
• Retinal Physiology
• Synaptic Transmission
• +۳ مورد دیگر

Dr. Andreas Feigenspan is a Professor of Neurobiology at the Department of Biology, Friedrich-Alexander University Erlangen-Nürnberg. Based in Erlangen, Germany (Room 00.144, Building A1), he focuses on retinal physiology, synaptic transmission, and ion channel dynamics through experimental and computational approaches. Research Interests: Neurobiology, Retinal Physiology, Synaptic Transmission, Ion Channels, Neural Networks, and Machine Learning applications in neuroscience. Key Research Themes: His work explores molecular mechanisms in retinal signal processing, calcium channel modulation in oligodendrocytes, synaptic plasticity in photoreceptor networks, and computational models of neural circuits. Recent Article Trends: Analysis of voltage-gated channels, synaptic protein disruptions (e.g., Bassoon), machine learning applications in synaptic current detection, and comparative studies between biological and artificial neural networks. Contact: Email andreas.feigenspan@fau.de or visit the Neurobiology Research Group website.

Donatella Pontiمشاهده پروفایل

پژوهشگر

• Molecular Biology
• Cancer Research
• Nucleolar Metabolism
• +۶ مورد دیگر

Donatella Ponti is a Researcher (RU) in the Department of Medical-Surgical Sciences and Biotechnologies at the University of Rome "Sapienza," specializing in MEDS-02/A (MED04) General Pathology. She serves as President of the Course in Childhood Neuro and Psychomotricity and is responsible for courses in Molecular Oncology and Molecular Pathology at the Medical Faculty. Her academic career spans over two decades with a permanent research position since December 2010. Dr. Ponti earned her PhD in Biochemistry from University La Sapienza di Roma (1998-2001) under Prof. D. Barra. Prior to this, she completed a School in Biotechnology (summa cum laude) at University of Rome La Sapienza and a Biological Sciences Degree (summa cum laude) from University "La Sapienza" Rome. Her research focuses on molecular mechanisms of disease, particularly nuclear and nucleolar trafficking, protein expression, and DNA manipulation. She investigates the nucleolus as a central hub in cancer proliferation, with emphasis on receptors and transcriptional factors that modulate cell proliferation through nucleolar metabolism. Her work bridges molecular biology, cancer research, and cellular signaling pathways, with particular interest in ErbB3 receptor signaling and its nucleolar localization in glioblastoma. The thematic areas of her research include Biotechnology, Molecular Biology, Biochemistry, Cell Pathology, nucleolar metabolism, immunometabolism, and ribosome biogenesis. Her publication record demonstrates a clear trajectory from fundamental molecular biology toward translational cancer research. Early work focused on ribosomal RNA processing and antimicrobial peptides, while more recent publications center on nucleolar metabolism in cancer cells, macrophage cross-talk in tumor microenvironments, and therapeutic targeting of nucleolar dysfunction. A consistent theme across her 31 publications is the exploration of non-canonical pathways involved in cancer proliferation under nucleolar control. Dr. Ponti has received recognition for her scientific contributions: DAAD Fellowship (2017) for research at Heidelberg University Award for thesis in Biotechnology from University of Rome Sapienza (1997) Member of National Register of Biologist (since 2009) As an academic advisor, Dr. Ponti has supervised numerous graduate students including Federico Forzati, Aurora Mosetti, Selenia di Rosa, and Marzia Tagliaferro. Her research has been supported by multiple competitive grants including Sapienza University funding (2015-2024), MIUR funding, and a DAAD scholarship. She currently serves as Principal Investigator for projects including "Fibrillarin and the Nucleolus in Human Macrophage Polarization" and "Nucleolar ErbB3: A NEW TARGET IN GLIOBLASTOMA." Dr. Ponti leads research in the Instrumental Laboratory at the Department of Medical-Surgical Science and Biotechnologies and has previously supervised the animal laboratory at the same department. Her laboratory investigates cellular models including cell lines and mouse models to study molecular mechanisms of disease, with particular focus on nucleolar metabolism in cancer contexts.

• Genitourinary Oncology
• Predictive Biomarkers
• Novel Therapeutics Development
• +۴ مورد دیگر

Benjamin L. Maughan, MD, PharmD serves as Associate Professor in the Division of Medical Oncology within the Department of Internal Medicine at the University of Utah's Huntsman Cancer Institute. His clinical focus centers on genitourinary malignancies with appointments at Farmington Health Center and Huntsman Cancer Institute. His educational background includes: PharmD, cum laude from Idaho State University College of Pharmacy (2004) Oncology Pharmacy Residency at St. Luke's Mountain States Tumor Institute (2005) MD, cum laude from University of Kentucky College of Medicine (2010) Internal Medicine Residency at University of Utah School of Medicine (2013) Medical Oncology Fellowship at Johns Hopkins University (2016) Dr. Maughan's research concentrates on predictive biomarker development and novel therapeutics for genitourinary cancers, particularly metastatic prostate, kidney, and bladder cancers. His work explores immune therapy combinations including checkpoint inhibitors with radiation therapy (radium-223), oncolytic viruses (MVA-brachyury), and targeted therapies (cabozantinib). He investigates truncated androgen receptors (AR-V7) and tumor suppressor loss (PTEN/Rb) as biomarkers in prostate cancer. His recent publications demonstrate strong focus on biomarker validation, immunotherapy combinations, and real-world treatment patterns across genitourinary malignancies, with particular emphasis on renal cell carcinoma and prostate cancer subtypes. Current research trends show increasing integration of genomic profiling with clinical outcomes assessment. Scientific recognition includes: Huntsman Cancer Institute Translational Scholar Award (2019) SWOG Young Investigator Training Course selection (2019) Dr. Maughan leads clinical trials including a SWOG study exploring novel treatments for metastatic papillary kidney cancer. His patient care philosophy emphasizes detailed explanation and compassionate communication, reflected in consistently high patient satisfaction scores (4.9/5 from 256 reviews). He holds board certifications in Internal Medicine and Medical Oncology from the American Board of Internal Medicine.

Xun Liمشاهده پروفایل

دانشیار

• Anti-tumor agents
• Peptidomimetics
• Multidrug resistance (MDR)
• +۴ مورد دیگر

Xun Li is an Associate Professor in the Department of Medicinal Chemistry at the School of Pharmaceutical Science, Shandong University. She has been affiliated with the institution since 2004, holding roles as Lecturer, Postdoctoral Fellow, and Associate Professor. Education: Ph.D. in Chemistry from Shandong University and Tianjin University (2004), B.S. in Chemistry from Qufu Normal University (1999). Professional Experience: 2004-2006 Lecturer & Postdoctoral Fellow; 2006-present Associate Professor; Visiting Scholar at Tokyo University (2007, 2008). Her research focuses on anti-tumor agents , peptidomimetics , multidrug resistance (MDR) reversal , matrix metalloproteinase (MMP) inhibitors , and aminopeptidase N (APN) inhibitors . She has published extensively on quinoxalinone derivatives and their roles in cancer therapy. Scientific Awards include: Excellent Postdoctoral Research Fellowship of China (2005) Youth Research Fellowship of 40th IUPAC (2005) Second-Class Shandong Province Science and Technology Progress Award (2012) She has secured multiple grants , including National Natural Foundation Research Grants and Japan-China Collaborative Research Grants, and holds several patents for quinoxalinone derivatives with MDR reversal and MMP inhibition activity.

Swarna Basuمشاهده پروفایل

استاد

• Physical Chemistry
• Biophysical Chemistry
• Nanoscience
• +۵ مورد دیگر

Swarna Basu is Professor and Head of the Department of Chemistry at Susquehanna University, where she has held progressive faculty positions since 2005 (Assistant Professor 2005-2011, Associate Professor 2011-2016, Professor 2016-present). She holds a PhD and MA from Wesleyan University and a BA from Clark University. Education PhD, Wesleyan University MA, Wesleyan University BA, Clark University Research Focus Dr. Basu leads an interdisciplinary physical/biophysical chemistry research program with three core themes: 1) Synthesis and functionalization of metallic nanoparticles (Au, Ag, ZnO) via conventional and green methods for biological applications including antibacterial agents, dye degradation, and Raman enhancement; 2) Protein/polymer cross-linking for smart biomaterials and drug delivery systems; 3) Spectroscopy-based investigations of metal complex interactions with proteins and DNA structures. Her work emphasizes instrument development, including custom microscopy and LabVIEW-based photochemical systems. Publication Analysis Her recent work (2012-2025) demonstrates strong focus on nanomaterial applications in biomedicine (cancer therapy, immunomodulation) and DNA biochemistry, particularly quadruplex DNA interactions with neurotransmitters/metal complexes. Methodologies frequently combine fluorescence/Raman spectroscopy with computational modeling, reflecting her physical chemistry expertise. Awards and Recognition John C. Horn Distinguished Service Award (2015) Invited Public Lecture: "Size Matters: Tiny Dots and Their Potential" (2016) Tishler Teaching Award (2002) Teaching and Mentoring She teaches undergraduate courses including General Chemistry, Physical Chemistry, Nanoscience, and research seminars. Actively mentors undergraduate researchers, with collaborative projects frequently resulting in co-authored publications and conference presentations.

Bryan Phillipsمشاهده پروفایل

استاد

• Cell and Developmental Biology
• Genetics
• Wnt Signaling Pathway
• +۳ مورد دیگر

Bryan Phillips is a Professor in the Department of Biology at the University of Iowa, where he conducts research on cell fate determination and developmental biology using C. elegans as a model organism. His work focuses on understanding how a single undifferentiated oocyte develops into a multicellular organism with numerous, intricately connected cell types through precise molecular mechanisms. Dr. Phillips received his PhD from Texas A&M University. His research primarily investigates the molecular mechanisms of cell-to-cell communication during development, with a particular emphasis on the Wnt signaling pathway and its role in asymmetric cell division where a polarized mother cell generates two daughter cells with different fate determinants. Dr. Phillips' laboratory examines how the Wnt signaling pathway regulates cell fate through β-catenin, with a special focus on SYS-1, a β-catenin homolog in C. elegans that shares structural and functional similarities with vertebrate β-catenin. His research explores how centrosomes, protein degradation mechanisms, and gene duplication events contribute to the regulation of asymmetric cell divisions. The lab's work bridges molecular, cellular, and developmental biology to address fundamental questions about why animal cells differentiate the way they do, with implications for developmental defects and diseases like cancer where Wnt signaling is often misregulated. Analysis of Dr. Phillips' publication record reveals a consistent research trajectory focused on Wnt signaling, β-catenin regulation, and asymmetric cell division across 15 recent publications (2015-2025). His work demonstrates how conserved molecular mechanisms control cell fate determination, with particular attention to the SYS-1 protein and its regulation through centrosomal localization, proteasomal degradation, and transcriptional activation. The research spans multiple levels of investigation from protein structure and evolutionary analysis to developmental processes in a whole organism. Dr. Phillips' laboratory is actively recruiting graduate students through multiple programs including the UI Biology Department, the UI Genetics Program, the UI Molecular and Cellular Biology Program, and the UI Biosciences Program. His research facilities are located in the Biology Building East (BBE) at the University of Iowa, where he maintains both office space (200 BBE) and laboratory facilities with dedicated phone lines for administrative and research communications.

Hanne Røberg-Larsenمشاهده پروفایل

دانشیار

• Bioanalytical Chemistry
• Liquid Chromatography–Mass Spectrometry (LC-MS)
• Oxysterol Analysis
• +۶ مورد دیگر

Hanne Røberg-Larsen is an Associate Professor at the University of Oslo, positioned within the Section for Chemical Life Sciences – Biomolecules, Bio-Inspired Materials and Bioanalytical Chemistry. Her work sits at the intersection of advanced analytical chemistry and biomedical research, where she develops and applies cutting-edge LC-MS technologies to address complex biological questions. Research Focus: Bioanalytical method development using nano- and capillary-LC–MS Oxysterol biology and lipid signalling in cancer and metabolic disease Single-cell and ultra-small sample omics Organoid and organ-on-chip analytics Automated sample preparation and microfluidic integration Across more than 40 peer-reviewed papers (2012-2025), her group has progressively pushed sensitivity limits for detecting metabolites, hormones and drugs in miniaturised systems. Recent trends reveal a strong emphasis on in vitro microphysiological models—combining organoids, organ-on-chip devices and tailored LC-MS workflows—to study metabolic crosstalk and therapeutic responses under controlled conditions. Particular attention is given to cholesterol-derived signalling molecules (oxysterols) and their impact on breast cancer chemoresistance and non-alcoholic fatty liver disease. Collaborative Environment: She participates in the strategic research initiative “Integrated technologies for tracking organoid morphogenesis (ITOM)” and is affiliated with the Bio3 research group “Chemical Life Sciences – Biomolecules, Bio-Inspired Materials and Bioanalytical Chemistry”. The group fosters interdisciplinary collaborations bridging chemistry, biology and engineering. No explicit funding details, awards or student lists were present in the supplied material.

• Food molecular functionality
• Health science
• Nutrigenetics
• +۴ مورد دیگر

Satoshi Yano is an Assistant Professor (non-tenure-track) at Waseda University's Faculty of Human Sciences, specializing in the molecular mechanisms of food functionality with applications in health promotion and disease prevention. His research integrates food science, molecular biology, and cellular mechanisms to elucidate how dietary components influence cellular processes relevant to aging and health. Dr. Yano's research interests focus on food molecular functionality, health science, nutrigenetics, bioinformatics, functional foods, autophagy, and exosomes. His work primarily investigates how specific food compounds—including wasabi components, fermented garlic, plant polyphenols, and D-amino acids—affect cellular processes such as autophagy, proteostasis, stress responses, and cell signaling pathways. His approach combines omics technologies, cell culture models, and molecular techniques to uncover the mechanisms by which food components exert their biological effects. Analysis of his publication record reveals a strong focus on autophagy regulation by food components, with significant contributions to understanding how dietary factors influence cellular homeostasis, stress response, and aging-related processes. His work spans multiple disciplines including food science, molecular biology, dermatology, and cancer research, demonstrating the interdisciplinary nature of his research on food functionality. Dr. Yano has received numerous scientific awards including the Encouragement Award from the International Taurine Research Society Japan Division (2025), multiple presentation awards at food science conferences, and prestigious university honors from Kagoshima University. His research has been supported by competitive grants from the Japan Society for the Promotion of Science and Waseda University's research foundation. As an educator, Dr. Yano teaches courses in Data Literacy, Student Life and Self-Management, Study Skills, and Basic Seminar II at Waseda University's School of Human Sciences. He also serves on various academic committees including the Secretariat of the 45th Joint Symposium of the Japan Society for Basic Gerontology and the Food for Health International Conference Executive Committee.

• Pediatric Lung Disease Detection
• Respiratory Medicine
• Cystic Fibrosis
• +۳ مورد دیگر

Clinical Professor Paul Robinson is a leading clinician-researcher at the University of Sydney's Discipline of Paediatrics and Child Health , with clinical specialization at The Children's Hospital at Westmead and research affiliations with the Woolcock Medical Research Institute . As Director of the Australian Central Over-Reading Centre (CORC) network, he standardizes Multiple Breath Washout (MBW) and Oscillometry testing globally. His work bridges clinical practice and translational research in pediatric respiratory medicine. Member of Charles Perkins Centre International collaborations with University of Toronto , Central Hospital Skovde , and Royal Brompton Hospital Research Interests : Targeting early detection of peripheral airway disease in pediatrics using MBW and Oscillometry —tools that assess nearly 95% of lung volume previously considered 'silent.' These methods are feasible across all pediatric ages and form the basis for clinical translation in Cystic Fibrosis , Asthma , and Post-Transplantation Monitoring . His team explores structure-function relationships through CT and MRI integration. Article Trends (2013–2025) show sustained focus on MBW/Oscillometry standardization, pediatric respiratory disease mechanisms, and clinical translation. Key areas include CF lung disease , asthma control , and environmental health impacts like bushfire smoke. Collaborations span Canada , Sweden , and UK . Scientific Awards include multiple TSANZ and ANZSRS best presentation awards (2006–2021), NHMRC PhD scholarship (2008), and leadership recognition through ATS Paediatric Assembly Chair roles. Teaching & Supervision involves medical students, junior staff training, and higher research candidates. Current Projects (2015–2025) span NHMRC , Asthma Australia , and Sydney Medical School Foundation grants, focusing on maternal asthma effects , home-based asthma monitoring , and post-transplantation complications .

Christopher Gernerمشاهده پروفایل

استاد

• Proteomics
• Mass Spectrometry
• Cancer Research
• +۷ مورد دیگر

Christopher Gerner is a Professor at the University of Vienna, holding positions in the Faculty of Chemistry, Institute of Analytical Chemistry, Department of Microbiology and Ecosystem Research, and Center for Microbiology and Environmental Systems Science. He directs the Mass Spectrometry Center and maintains an active research program spanning proteomics, metabolomics, and lipidomics with applications in cancer research and drug development. His research focuses on Proteomics , Mass Spectrometry , Cancer Research , Metabolomics , Lipidomics , and Systems Biology , with particular expertise in cancer cell biology, tumor microenvironment, and drug mechanism studies. His work contributes significantly to understanding ovarian cancer, metastatic melanoma, and inflammatory responses through multi-omics approaches. Dr. Gerner's publication record shows consistent productivity with over 245 publications spanning from 2008 to present, with recent work increasingly focusing on morphometabolic fingerprinting of ovarian cancer, PFAS toxicity, and the biophysical properties of tumor microenvironments. His research integrates proteomics with metabolomics to provide comprehensive molecular insights into disease mechanisms. Best Poster Preis - HPLC 2017: 45th International Symposium on High Performance Liquid Phase Separations and Related Techniques (June 18, 2017) Best Poster Prize - Symposium 'Advances in Chromatography and Electrophoresis & Chiranal 2018' (January 29, 2018) Dr. Gerner leads the ongoing research project 'Morphometabolic fingerprint of ovarian cancer' (2022-2026) in collaboration with Del Favero, Köllensperger, and Zanghellini. His laboratory activities include the Mass Spectrometry Center which serves as a hub for proteomics and metabolomics research at the University of Vienna, supporting both basic and translational research projects across multiple disciplines.

Annette Bayerمشاهده پروفایل

استاد

• Organic Chemistry
• Medicinal Chemistry
• Antibiotic Resistance
• +۷ مورد دیگر

Annette Bayer is a Professor at the Department of Chemistry, UiT The Arctic University of Norway, specializing in chemical synthesis and analysis. Her research focuses on developing antimicrobial agents, overcoming antibiotic resistance, and utilizing carbon dioxide in synthetic chemistry. Her work includes designing phenylboronic acid-based inhibitors to restore β-lactam antibiotic efficacy against KPC-2-producing Klebsiella pneumoniae, exploring fluorinated captopril analogues to inhibit metallo-β-lactamases, and investigating asymmetric boracarboxylation reactions using CO 2 as a C1 source. She also develops amphipathic barbiturates and hydantoins as membranolytic antimicrobials, with applications in cancer therapy and biofilm disruption. Recent publications highlight her team's progress in liposomal delivery of antimicrobial mimics, DNA micelle formulations for sustained antibacterial activity, and sustainable solvent systems like lipids for catalytic reactions. Her 2023 article in Frontiers in Pharmacology demonstrated cytolytic and immunogenic effects of marine-inspired barbiturates on head and neck cancer cells. Teaching innovations include restructuring organic chemistry courses to improve learning outcomes and advocating for part-time oral exams as an efficient assessment method.

• Cancer Nanotechnology
• Solid Tumour Biology
• Pharmacology
• +۷ مورد دیگر

Professor Marilena Loizidou is a distinguished academic at University College London (UCL), where she serves as Professor of Cancer Nanotechnology in the Department of Surgical Biotechnology. She holds significant leadership positions as Deputy Director of the Division of Surgery and Interventional Science (SIS) at UCL and Head of the SIS Department at the Royal Free Campus. Her work bridges the fields of cancer biology, nanotechnology, and surgical sciences, with a particular focus on developing innovative approaches to cancer treatment and diagnostics. Professor Loizidou's educational background includes: PhD in Solid Tumour Biology and Pharmacology from the University of Southampton (1991) MSc from the University of Southampton (1985) BSc in Biochemistry from McMaster University, Canada (1984) Her primary research interests center on cancer nanotechnology and the development of tumouroids - complex 3D in vitro cancer models that mimic the composition and architecture of solid tumors. Professor Loizidou has pioneered the use of these tumouroids as platforms for therapeutic testing and precision medicine applications. Her work specifically targets solid tumors, with emphasis on colorectal cancer and the role of the fibrotic cancer stroma in tumor progression and treatment resistance. She applies nanotechnology tools to improve drug targeting and develop novel imaging techniques for cancer diagnosis and treatment monitoring. Analysis of Professor Loizidou's recent publication record (2023-2025) reveals a strong focus on advancing 3D cancer modeling through tumouroids, with particular attention to renal cell carcinoma, ovarian cancer, and prostate cancer. Her research explores the mechanical properties of tumor microenvironments, fibrotic remodeling processes, and the development of biomimetic materials that accurately replicate cancer tissue characteristics. A significant portion of her work investigates how nanotechnology can be leveraged to improve drug delivery and therapeutic efficacy in solid tumors. These research directions demonstrate a consistent trajectory toward developing more clinically relevant cancer models and translating laboratory findings into potential clinical applications. Professional distinctions include: Elected council member of the Society for Academic and Research Surgery (SARS) from 2009-2013 Professor Loizidou has made substantial contributions to academic education and mentorship. She currently serves as Director of the MSc in Surgical and Interventional Sciences and Co-Director of the MSc in Nanotechnology and Regenerative Medicine. Previously, she co-founded and directed the Intercalated BSc in Surgical Sciences and served as Co-Director of the MSc in Evidence-based Healthcare in Surgery. Her educational leadership demonstrates a commitment to training the next generation of surgical scientists and clinicians in innovative approaches to medicine. Her research group operates at the intersection of cancer biology, nanotechnology, and surgical science, focusing particularly on developing and utilizing tumouroids as sophisticated models for cancer research. The team employs advanced techniques in tissue engineering, 3D modeling, and nanotechnology to investigate tumor-stroma interactions and develop improved therapeutic strategies. Through collaborations across disciplines, Professor Loizidou's laboratory continues to advance our understanding of solid tumor biology and develop innovative approaches to cancer treatment.

Jörgen Olssonمشاهده پروفایل

استاد

• Solid-State Electronics
• High-frequency MOS-based devices
• SOI-technology
• +۴ مورد دیگر

Professor Jörgen Olsson is a faculty member at Uppsala University's Department of Materials Science and Engineering with a specialization in Solar Cell Technology. He serves as Deputy Head of Department and Director of Postgraduate Studies, while also participating in multiple university committees including the Doctoral Education Board (FUN), Teknat Faculty Advisory Committees for both Research and Education, and the Teknat Equal Opportunities Committee. Ph.D. in Electronics from Uppsala University (1996) Visiting Scientist at Digital Semiconductor, Hudson, MA (1997) Promoted to Professor in Solid-State Electronics (2008) Professor Olsson's research spans semiconductor device physics with evolving focus areas. Early work centered on high-frequency MOS-based devices, SOI-technology, and RF-power devices. His more recent research has shifted toward photovoltaics, particularly thin-film solar cells including CIGS and CZTS technologies. His publications demonstrate expertise in both fundamental semiconductor physics and practical device applications, with significant contributions to understanding device behavior under various conditions. Analysis of his recent publications (2016-2022) reveals a dual research trajectory: continued work on RF power devices and amplifiers for particle accelerators, alongside growing contributions to photovoltaic technology. His work bridges electrical engineering and materials science, with applications ranging from wireless communications to renewable energy. The consistent publication record demonstrates sustained research productivity across multiple domains of semiconductor device physics. Professor Olsson has served in significant academic leadership roles including Director of Postgraduate Studies and Deputy Head of Department. His extensive publication record (over 180 scientific papers) indicates substantial research activity and mentorship within his field. His work with the Doctoral Education Board suggests active involvement in graduate education and academic program development. At the Ångström Laboratory, Professor Olsson headed the Solid State Device Group, where research spanned semiconductor device fabrication, characterization, and modeling. His work connects fundamental device physics with practical applications in both electronics and renewable energy sectors, reflecting the interdisciplinary nature of modern materials science research.

Vilma Yuzbasiyan-Gurkanمشاهده پروفایل

استاد

• Comparative Oncology
• Cancer Genetics
• Veterinary Genetics
• +۳ مورد دیگر

Dr. Vilma Yuzbasiyan-Gurkan is a Professor in the Department of Microbiology, Genetics, & Immunology at Michigan State University (MSU). Her research bridges comparative oncology, veterinary genetics, and human disease models, focusing on genetic disorders and cancers in companion animals. Education: B.A., 1978, Vassar College Ph.D., 1983, University of Istanbul Medical School Postdoctoral, 1984-1988, University of Michigan Research Interests: Dr. Yuzbasiyan-Gurkan's work spans comparative oncology and genetic disease modeling , particularly in canine and feline populations. Key areas include mutation discovery (e.g., KIT , PTPN11 ), targeted therapy development (e.g., MEK inhibitors ), and epigenetic profiling of cancers. Her lab emphasizes translational applications, such as liquid biopsy for early detection and microRNA-based treatments for metastatic disease. Article Trends: Her publications reflect a focus on comparative genomics (e.g., KRAS/PTPN11 mutations), epigenetic mechanisms (e.g., methylation patterns), and novel therapeutics (e.g., STING activators, proteasome modulators). Collaborations with chemists (Dr. Jetze Tepe), vaccinologists (Dr. Xuefei Huang), and biomedical engineers (Dr. Anna Moore) underscore interdisciplinary approaches. Collaborative Grants: Dr. Yuzbasiyan-Gurkan has secured funding for multi-omics studies of genetic diseases, comparative cancer trials , and veterinary-student training programs (e.g., BRUSH summer initiative). Her work frequently explores zoonotic parallels between animal and human oncology. Labs & Teams: She leads a team at the 5172 Biomed Phys Sci facility at MSU, integrating genomics, molecular biology, and clinical trials. Her lab collaborates with veterinary practitioners, pharmaceutical researchers, and computational biologists to refine animal models of human disease .